Generic Drug Group Revives Ask for Pause on Illinois Pricing Law

The national group representing generic drug and biosimilar manufacturers is looking to replicate its success challenging state pricing limits with a motion filed Friday requesting a federal judge pause enforcement of an Illinois anti-price gouging law.

Members of the Association for Accessible Medicines face a high risk of penalties under the state statute prohibiting excessive price gouging on generic and other off-patent drugs, the organization wrote in its brief filed in the US District Court for the Northern District of Illinois.

AAM argued it is likely to succeed on its claim that the Illinois law is unconstitutional “by directly regulating ...